+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

AL Amyloidosis - Pipeline Insight, 2024 - Product Thumbnail Image

AL Amyloidosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Somatotropin deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Somatotropin deficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Type 1 Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Graves' Orbitopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Graves' Orbitopathy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Batten Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Batten Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
JARDIANCE Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

JARDIANCE Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
FARXIGA Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

FARXIGA Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Diabetic Nephropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Nephropathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Diabetic Foot Ulcers - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Foot Ulcers - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Gouty Arthritis (Gout) - Pipeline Insight, 2024 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Fabry Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Fabry Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Lactose Intolerance - Pipeline Insight, 2024 - Product Thumbnail Image

Lactose Intolerance - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Proteus Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Proteus Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Phosphoglucomutase (PGM 1) Deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Phosphoglucomutase (PGM 1) Deficiency - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acid sphingomyelinase deficiency (ASMD) - Pipeline Insight, 2024 - Product Thumbnail Image

Acid sphingomyelinase deficiency (ASMD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Adrenal Insufficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenal Insufficiency - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acromegaly and Gigantism Therapeutics - Pipeline Insight, 2024 - Product Thumbnail Image

Acromegaly and Gigantism Therapeutics - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Adult Growth Hormone Deficiency (AGHD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more